LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Laboratory Diagnosis Required for Treating Patients with Persistent Diarrhea

By LabMedica International staff writers
Posted on 13 Jul 2016
Print article
Image: The protozoan parasite Dientamoeba fragilis from a stool sample. Trophozoites exhibit an amoeba-like morphology and are often bi-nucleated (Photo courtesy of Tulane University).
Image: The protozoan parasite Dientamoeba fragilis from a stool sample. Trophozoites exhibit an amoeba-like morphology and are often bi-nucleated (Photo courtesy of Tulane University).
Persistent diarrhea, which is diarrhea that lasts at least 14 days, is an illness typically caused by parasites or bacteria and requires accurate diagnosis in order to determine the proper etiologic diagnosis which is important for appropriate therapeutic management.

Much of the data on persistent diarrhea comes from studies of residents in or expatriates of developing countries and travelers to these regions where follow-up studies have been performed and persistent diarrhea occurs in approximately 3% of individuals traveling to developing countries.

The Director of the Center for Infectious Diseases at The University of Texas Health Science Center (Houston, TX, USA) has reviewed the facts pertaining to persistent diahrrea. Acute diarrhea lasts less than two weeks and is typically caused by viruses or toxins. Persistent diarrhea is most commonly caused by bacteria or parasites, including Giardia, Cryptosporidium and Cyclospora. Less common parasites are Entamoeba, Cystoisospora belli (Isospora belli), Dientamoeba fragilis, Strongloides stercoralis and microsporidia. These parasites, which can be detected in laboratory testing, can be contracted through food, water or from other people and are commonly picked up while traveling.

Previously, microbiologists would culture bacteria from a stool sample and examine it for isolated bacteria. For parasites, they would either look under a microscope or, for three of the parasites, use commercial enzyme immunoassays. Both methods were only able to identify a small number of parasites. A novel testing method called multiplex polymerase chain reaction (PCR) was developed within the past year. This simultaneous, single test identifies unique DNA sequences to detect a panel of causes of diarrhea. Two multiplex platforms are commercially available: the xTAG Gastrointestinal Pathogen Panel (Luminex Corporation, Austin TX, USA), which tests for 14 viruses, bacteria, and parasites and the FilmArray GI panel (Biofire Diagnostics, Salt Lake City, UT, USA) that tests for 22 viruses, bacteria, and parasites.

Herbert L. DuPont, MD, the author of the review said, “These new tests are easy to use, are capable of detecting a broad range of pathogens and represent a significant improvement over culture-based diagnostic approaches. The technology needs to be more widely available. Diagnosis is critical when treating persistent diarrhea. Antimicrobial therapy can be useful for many patients with persistent diarrhea, but a lab-established diagnosis is necessary for treatment.” The study was published in the June 2016 issue of the Journal of the American Medical Association.

Related Links:
The University of Texas Health Science Center
Luminex
Biofire Diagnostics
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more